Completed NA INTERVENTIONAL 2-arm NCT01738399

Coffee and Metabolic Health Outcomes (COMETH)

Influence of Coffee Consumption on Insulin Sensitivity in Overweight and Insulin Resistant Subjects.

Sponsor: National University Hospital, Singapore

Updated 6 times since 2017 Last updated: Apr 21, 2015 Started: Apr 30, 2012 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Insulin Resistance, this trial is completed. The trial is conducted by National University Hospital, Singapore and has accumulated 6 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2023 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Mar 2023 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National University Hospital, Singapore
Société des Produits Nestlé (SPN)

Data source: National University Hospital, Singapore

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Singapore, Singapore